Atherosclerotic Occlusive Disease — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for atherosclerotic occlusive disease. 15 active patents protecting 1 drugs from 1+ originators. First major cliff: 2030. Daily refresh.

1
Approved drugs
15
Active US patents
46/100
Avg vulnerability
—
Annual revenue covered

Originators in Atherosclerotic Occlusive Disease

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Esperion Theraps Inc 15 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating atherosclerotic occlusive disease. Each bar = one year. Y-axis scaled to peak year (10 patents).

2
30
3
36
10
40

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Nexletol
BEMPEDOIC ACID
 Esperion Theraps Inc 15 46 — 2030-12-03

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11744816 Nexletol method of use 75 2036-03-14
12404227 Nexletol method of use 75 2040-06-19
11926584 Nexletol method of use 75 2040-06-19
11926584 Nexletol method of use 75 2040-06-19
12404227 Nexletol method of use 75 2040-06-19
11744816 Nexletol method of use 70 2036-03-14
10912751 Nexletol method of use 62 2036-03-14
11760714 Nexletol formulation 50 2040-06-19
11760714 Nexletol formulation 50 2040-06-19
12398087 Nexletol composition of matter 17 2040-06-19

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
7335799 Nexletol composition of matter 10 2030-12-03
7335799 Nexletol composition of matter 10 2030-12-03
11613511 Nexletol composition of matter 12 2040-06-19
11613511 Nexletol composition of matter 12 2040-06-19
12398087 Nexletol composition of matter 17 2040-06-19
12398087 Nexletol composition of matter 17 2040-06-19
11760714 Nexletol formulation 50 2040-06-19
11760714 Nexletol formulation 50 2040-06-19
10912751 Nexletol method of use 62 2036-03-14
11744816 Nexletol method of use 70 2036-03-14

Related